KFDA approved additional indication for Wyeth Enbrel.

Published: 2005-07-21 06:58:00

Updated: 2005-07-21 06:58:00

The KFDA approved Enbrel for the indication of ringworm in addition to its rheumatoid arthritis, especially for the patients who are moderate to severe ringwom diseases and resistant to other treatments as available.

At present Enbrel was approved for the treatments of rheumatoid arthritis, r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK